Search

everythinglearnresearchcommunity

for

Search:↓

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

A dog with unusual skin lesions near its tail was successfully treated for a rare form of lupus.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Low vitamin D levels are common in people with Alopecia Areata.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

The document recommends a team-based approach and personalized care for managing diabetes in teenagers.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Oxidative stress is linked to mild patchy alopecia areata.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.